Estimating the burden and economic impact of trachomatous visual loss

Ophthalmic Epidemiology

Volumn 10, Issue 2, 2003, Pages 121-132

  Frick, Kevin D ^a,b   Basilion, Eva V ^c   Hanson, Christy L ^b   Colchero, M Arantxa ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c International Trachoma Initiative   (United States)

Author keywords

Blindness; Burden of disease; Low vision; Productivity loss; Trachoma

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BLINDNESS; CALCULATION; DISABILITY; ECONOMIC ASPECT; HUMAN; PRIORITY JOURNAL; PRODUCTIVITY; RESOURCE ALLOCATION; SEX RATIO; TRACHOMA; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGED; BLINDNESS; COST OF ILLNESS; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; TRACHOMA; VISUALLY IMPAIRED PERSONS; WORLD HEALTH;

EID: 0344838536     PISSN: 09286586     EISSN: None     Source Type: Journal    
DOI: 10.1076/opep.10.2.121.13899     Document Type: Article

References (35)

1. Report of the First Meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva: World Health Organization, 1997. (Unpublished document WHO/PBL/GET/97.1).
2. Dawson C, Schachter J. Can blinding trachoma be eliminated worldwide? Arch Ophthalmol. 1999;117(7):974.
3. Limburg H, Bah M, Johnson GJ. Trial of the Trachoma Rapid Assessment methodology in The Gambia. Ophthalmic Epidemiol. 2001;8(2-3):73-85.
4. Frick KD, West SK. The SAFE strategy for trachoma control: Planning a cost-effectiveness analysis of the antibiotic component and beyond. Ophthalmic Epidemiol. 2001;8(4):205-214.
5. Frick KD, Keuffel E, Bowman RJC. Epidemiological, demographic, and economic analyses: Measurement of the value of trichiasis surgery in the Gambia. Ophthalmic Epidemiol. 2001;8(2-3):191-201.
6. Frick KD, Lietman TM, Osaki Holm S, et al. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bull WHO. 2001;79(3):201-207.
7. Bowman RJ, Sillah A, Van Dehn C, et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci. 2000;41(13):4074-4079.
8. Evans TG, Ranson MK, Kyaw TA, Ko CK. Cost effectiveness and cost utility of preventing trachomatous visual impairment: Lessons from 30 years of trachoma control in Burma. Br J Ophthalmol. 1996;80(10):880-889.
9. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull WHO. 1995;73(1):115-121.
10. Murray CJL, Lopez AD, editors. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1996.
11. Ranson MK, Evans TG. The global burden of trachomatous visual impairment: I. Assessing prevalence. Int Ophthalmol. 1995-96;19(5):261-270.
12. Evans T, Ranson MK. The global burden of trachomatous visual impairment: II. Assessing burden. Int Ophthalmol. 1995-96;19(5):271-280.
13. Mansour AM, Kassak K, Chaya M, et al. National survey of blindness and low vision in Lebanon. Br J Ophthalmol. 1997;81(10):905-906.
14. Newland HS, Woodward AJ, Taumoepeau LA, et al. Epidemiology of blindness and visual impairment in the kingdom of Tonga. Br J Ophthalmol. 1994;78(5):344-348.
15. Schwartz EC, Huss R, Hopkins A, et al. Blindness and visual impairment in a region endemic for onchocerciasis in the Central African Republic. Br J Ophthalmol. 1997;81(6):443-447.
16. Al Faran MF. Low prevalence of trachoma in the south western part of Saudi Arabia, results of a population based study. Int Ophthalmol. 1994-95;18(6):379-382.
17. Negrel AD, Minassian DC, Sayek F. Blindness and low vision in southeast Turkey. Ophthalmic Epidemiol. 1996;3(3):127-134.
18. Future Approaches to Trachoma Control: Report of a Global Scientific Meeting. Geneva, 17-20 June 1996. (unpublished document WHO/PBL/96/56).
19. Taylor HR, Velasco FM, Sommer A. The ecology of trachoma: An epidemiological study in southern Mexico. Bull WHO. 1985;63(3):559-567.
20. Luna EJ, Medina NH, Oliveira MB, et al. Epidemiology of trachoma in Bebedouro State of Sao Paulo, Brazil: Prevalence and risk factors. Int J Epidemiol. 1992;21(1):169-177.
21. United Nations Population Division, Department of Economic and Social Affairs. World Population Prospects: The 1998 Revision. Vol. I: Comprehensive Tables; E.99.XIII.9;1998.
22. Koopmanschap MA, Rutten FF, Van Ineveld BM, Van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14(2):171-189.
23. Frick KD, Melia BM, Buhrmann RR, West SK. Trichiasis and disability in a Trachoma Endemic Area of Tanzania. Arch Ophthalmol. 2001;119(12):1839-1844.
24. Smith AF, Smith JG. The economic burden of global blindness: A price too high! Br J Ophthalmol. 1996;80(4):276-277.
25. Shamanna BR, Dandona L, Rao GN. Economic burden of blindness in India. Indian J Ophthalmol. 1998;46(3):169-172.
26. Over M, Bertozzi S, Chin J. Guidelines for rapid estimation of the direct and indirect costs of HIV infection in a developing country. Health Policy. 1989;11(2):169-186.
27. World Development Indicators 2000. Washington DC: World Bank, 2000.
28. The World Health Report 2000. Health Systems: Improving Performance. Geneva: World Health Organization, 2000.
29. Williams A. Calculating the global burden of disease: Time for a strategic reappraisal? Health Econ. 1999;8(1):1-8.
30. Mabey D, Bailey R. Eradication of trachoma worldwide. Br J Ophthalmol. 1999;83(11):1261-1263.
31. Mackey R. The way we live now: Salient facts: Global health campaigns; ten diseases on the way out. New York Times. May 6, 2001.
32. Resnikoff S, Pararajasegaram R. Blindness prevention programmes: Past, present, and future. Bull WHO. 2001;79(3):222-226.
33. Christian P, West KP, Jr, Khatry SK, et al. Night blindness during pregnancy and subsequent mortality among women in Nepal: Effects of vitamin A and beta-carotene supplementation. Am J Epidemiol. 2000;152(6):542-547.
34. Courtright P, Kim SH, Lee HS, Lewallen S. Excess mortality associated with blindness in leprosy patients in Korea. Lepr Rev. 1997;68(4):326-330.
35. Kirkwood B, Smith P, Marshall T, Prost A. Relationships between mortality, visual acuity and microfilarial load in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg. 1983;77(6):862-868.